Pramine and Ribavirin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pramine (imipramine hydrochloride) and Ribavirin (ribavirin). Common drug interactions include fatigue among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Pramine and Ribavirin. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Pramine?

Pramine has active ingredients of imipramine hydrochloride. eHealthMe is studying from 7,461 Pramine users. Check the latest studies of Pramine.

What is Ribavirin?

Ribavirin has active ingredients of ribavirin. It is often used in hepatitis c. eHealthMe is studying from 78,532 Ribavirin users. Check the latest studies of Ribavirin.



On Aug, 04, 2026

14 people who take Pramine and Ribavirin together, and have interactions are studied.

Pramine and Ribavirin drug interactions.

What are the common drug interactions of Pramine and Ribavirin, by gender? *:

female:

  1. Fatigue (feeling of tiredness)
  2. Anaemia (lack of blood)
  3. Nausea (feeling of having an urge to vomit)
  4. Dizziness
  5. Dyspnoea (difficult or laboured respiration)
  6. White blood cell count decreased
  7. Abdominal pain lower
  8. Acute respiratory failure
  9. Adverse event
  10. Anaemia vitamin b12 deficiency

male:

  1. Fatigue (feeling of tiredness)
  2. Syncope (loss of consciousness with an inability to maintain postural tone)
  3. Metastases to lung (cancer spreads to lung)
  4. Nephrolithiasis (calculi in the kidneys)
  5. Pulmonary oedema (fluid accumulation in the lungs)
  6. Tongue cancer recurrent (repeat cancer of tongue)
  7. Erythema (redness of the skin)
  8. Peripheral swelling
  9. Dizziness
  10. Asthenia (weakness)

What are the common drug interactions of Pramine and Ribavirin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Fatigue (feeling of tiredness)
  2. Syncope (loss of consciousness with an inability to maintain postural tone)
  3. Anaemia (lack of blood)
  4. Dizziness
  5. Nausea (feeling of having an urge to vomit)

50-59:

  1. Anaemia (lack of blood)
  2. Dizziness
  3. Dyspnoea (difficult or laboured respiration)
  4. Encephalopathy (functioning of the brain is affected by some agent or condition)
  5. Fatigue (feeling of tiredness)
  6. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  7. Pulmonary oedema (fluid accumulation in the lungs)
  8. White blood cell count decreased

60+:

  1. Erythema (redness of the skin)
  2. Peripheral swelling
  3. Diverticulum intestinal (a pouch that is attached to the first part of the small intestine)
  4. Dizziness
  5. Dyspnoea (difficult or laboured respiration)
  6. Fatigue (feeling of tiredness)
  7. Gastritis (inflammation of stomach)
  8. Haemoglobin decreased
  9. Hypertension (high blood pressure)
  10. Metastases to lung (cancer spreads to lung)

What are the existing conditions these people have? *

  1. Insomnia (sleeplessness): 2 people, 14.29%
  2. Hiv Infection: 2 people, 14.29%
  3. Depression: 2 people, 14.29%
  4. Type 2 Diabetes: 1 person, 7.14%
  5. Somatisation Disorder (a long-term (chronic) condition in which a person has physical symptoms that involve more than one part of the body): 1 person, 7.14%
  6. Sleep Disorder: 1 person, 7.14%
  7. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 1 person, 7.14%
  8. Migraine (headache): 1 person, 7.14%
  9. High Blood Pressure: 1 person, 7.14%
  10. Drug Dependence: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Pramine and Ribavirin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Pramine and Ribavirin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pramine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ribavirin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pramine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ribavirin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on imipramine hydrochloride and ribavirin (the active ingredients of Pramine and Ribavirin, respectively), and Pramine and Ribavirin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: